Literature DB >> 26438779

Response to Letter Regarding Article, "Familial Clustering of Mitral Valve Prolapse in the Community".

Francesca N Delling1, Jian Rong2, Martin G Larson3, Birgitta Lehman4, Ewa Osypiuk4, Plamen Stantchev4, Susan A Slaugenhaupt5, Emelia J Benjamin6, Robert A Levine7, Ramachandran S Vasan6.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26438779      PMCID： PMC4620666          DOI： 10.1161/CIRCULATIONAHA.115.016788

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  5 in total

1.  Familial clustering of mitral valve prolapse in the community.

Authors:  Francesca N Delling; Jian Rong; Martin G Larson; Birgitta Lehman; Ewa Osypiuk; Plamen Stantchev; Susan A Slaugenhaupt; Emelia J Benjamin; Robert A Levine; Ramachandran S Vasan
Journal:  Circulation       Date:  2014-10-31       Impact factor: 29.690

2.  Mild expression of mitral valve prolapse in the Framingham offspring: expanding the phenotypic spectrum.

Authors:  Francesca N Delling; Philimon Gona; Martin G Larson; Birgitta Lehman; Warren J Manning; Robert A Levine; Emelia J Benjamin; Ramachandran S Vasan
Journal:  J Am Soc Echocardiogr       Date:  2013-10-24       Impact factor: 5.251

3.  Prevalence and clinical outcome of mitral-valve prolapse.

Authors:  L A Freed; D Levy; R A Levine; M G Larson; J C Evans; D L Fuller; B Lehman; E J Benjamin
Journal:  N Engl J Med       Date:  1999-07-01       Impact factor: 91.245

4.  Risk, determinants, and outcome implications of progression of mitral regurgitation after diagnosis of mitral valve prolapse in a single community.

Authors:  Jean-Francois Avierinos; Delphine Detaint; David Messika-Zeitoun; Dania Mohty; Maurice Enriquez-Sarano
Journal:  Am J Cardiol       Date:  2008-01-16       Impact factor: 2.778

5.  Natural history of mitral valve prolapse.

Authors:  A Zuppiroli; M Rinaldi; R Kramer-Fox; S Favilli; M J Roman; R B Devereux
Journal:  Am J Cardiol       Date:  1995-05-15       Impact factor: 2.778
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.